Bryan Dirks, MD
- 3Articles
- 24.6KReads
- 2013–2020Active
- 15Collaborators
- 106Citations
About
Bryan Dirks, MD, has published research focused on major depressive disorder, including studies on adjunctive pimavanserin and its effects on sleep and treatment response. His work also encompasses neurodevelopmental psychiatry, specifically investigating lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder and executive function impairment. Dirks has contributed to clinical trials employing randomized, double-blind, placebo-controlled methodologies between 2013 and 2020.
Publications
Adjunctive Pimavanserin and Sleep/Wakefulness in MDD
December 1, 2020
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.